The smart electric carmaker, which has raised a reported $2.5bn from investors including Alibaba, Foxconn, UCar and Xiaomi, has set a placeholder target of $100m.

The chip manufacturing services firm is set to go public $268m in an oversubscribed offering that will enable Samsung, Xiaomi and Intel to exit.

The Softbank, Telstra and American Express-backed e-commerce software producer has closed its IPO after its shares more than tripled in price.

The number of corporate-backed companies going public declined in 2019, despite some major IPOs like those of Uber, Lyft and Slack.

Gene therapy developer Freeline Therapeutics priced an upsized offering at the top of its range following $275m in funding from investors including Novo.

UCL's Freeline Therapeutics has priced its shares at $18 to raise nearly $159m through an IPO on the Nasdaq Global Select Market.

Humana-backed primary care network Oak Street Health is raising $328m in an offering in which it priced its shares above an expanded range.

The Telstra, Softbank and American Express-backed e-commerce software provider BigCommerce floated above an expanded range.

Alibaba's financial services spinoff, which counts China Life and China Post as investors, has reportedly set a target for a dual offering that would be the largest in history.

Pfizer, Sanofi, Vertex Pharmaceuticals, Merck & Co and Amgen are in line for exits after the immunotherapy developer filed to go public.